Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $94.7400 (-2.43%) ($91.7900 - $99.1900) on Tue. Jan. 19, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.73% (three month average) | RSI | 36 | Latest Price | $94.7400(-2.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -4.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) XBI(57%) IWO(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.365% in a week (0% probabilities). VIXM(-17%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.365% (StdDev 2.73%) | Hourly BBV | 0 () | Intraday Trend | -3.7% | | | |
|
1 - 5 Day Possible Target | $87.78(-7.35%) | Resistance Level | $102.38 | 5 Day Moving Average | $96.79(-2.12%) | 10 Day Moving Average | $97.56(-2.89%) | 20 Day Moving Average | $102.38(-7.46%) | To recent high | -15.3% | To recent low | 9.8% | Market Cap | $1.523b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |